News

Medicis, a US based Aesthetics company, known for facial fillers like Restylane and Perlane will promote Dysport in the US as part of a sales agreement with the

Architect CORE is a chemiluminescent microparticle immunoassay (CMIA) used to detect IgG and IgM antibodies to hepatitis B core antigen (anti-HBc). The company includes hepatitis B test to

SDSU researchers lead by Chandradhar Dwivedi, Head, Department of Pharmaceutical Sciences, SDSU have found that treating human skin cancer cells with various concentrations of sarcophine-diol has inhibited the

Alkermes, a biotechnology company, has initiated two new clinical trials of ALKS 33, an oral opioid modulator for the potential treatment of addiction and other nervous system disorders.

Addrenex Pharmaceuticals, a specialty pharmaceutical company, has signed an agreement to license a new drug for the treatment of narcolepsy, as well as other neurologic and psychiatric conditions.

Lipoxen, a UK-based developer of drug and vaccine delivery systems, has received funding to apply its ImuXen technology to enhance the performance of malaria vaccine candidates. The PATH

ViraCor Laboratories, a provider of molecular diagnostic testing for infectious diseases, has launched a new cytomegalovirus antiviral resistance test that reportedly provides diagnosis days faster than other tests

Rafael Medical Technologies, a developer of intravascular devices, has received marketing clearance from FDA for its SafeFlo vena cava filter. The clearance is for the permanent implantation of

US-based Competitive Technologies has reported that its bone nanoparticle biomaterial technology has been issued a third patent supporting the first two patents and providing additional claims regarding the